[EN] NOVEL PYRIDAZINE COMPOUNDS FOR THE TREATMENT OF DIABETES<br/>[FR] NOUVEAUX COMPOSES DE PYRIDAZINE POUR LE TRAITEMENT DE DIABETES
申请人:BIOVITRUM AB
公开号:WO2002026743A1
公开(公告)日:2002-04-04
The present invention is directed to novel pyridazine compounds of the formula (I) as well as pharmaceutically and pharmaceutically acceptable salts, and hydrates thereof; to a process for their preparation, their use and pharmaceutical compositions comprising said novel compounds. These novel compounds are useful in therapy, particularly for the treatment of type 2 diabetes mellitus.
Novel compounds
申请人:——
公开号:US20020115663A1
公开(公告)日:2002-08-22
The present invention is directed to novel pyridazine compounds of the formula I
1
as well as pharmaceutically and pharmacologically acceptable salts, and hydrates thereof; to a process for their preparation, their use and pharmaceutical compositions comprising said novel compounds. These novel compounds are useful in therapy, particularly for the treatment of type 2 diabetes mellitus.